VII IFHNOS WORLD TOUR 2019

October 15-16, 2019 | Hotel Duman, Nur-Sultan, Kazakhstan

TRAVELLING FACULTY

Jatin P. SHAH

MD, PhD (Hon.), DSc (Hon), FACS, FRCS (Hon.), FDSRCS (Hon.), FRACS (Hon.), FRCSDS (Hon)

Professor Jatin Shah is an international leader who holds The Elliott W. Strong Chair in Head and Neck Oncology at Memorial Sloan Kettering Cancer Center in New York City. Professor Shah has served as President of The New York Cancer Society, The New York Head and Neck Society, The Society of Head and Neck Surgeons, The North American Skull Base Society, and the International Academy of Oral Oncology. He is Founder and CEO of The International Federation of Head and Neck Oncologic Societies (IFHNOS). Professor Shah has been the recipient of numerous awards from all continents and is an honorary member of several Head and Neck societies in Europe, Asia, Australia and South America. He serves on the Editorial and Review Boards of 18 scientific journals and has published more than 500 peer-reviewed publications, 78 book chapters and 10 books. His textbook of Head and Neck Surgery and Oncology won First Prize from The British Medical Association and The Royal Society of Medicine, and was awarded the George Davey Howells Prize from the University of London for the best published book in otolaryngology in the preceding five years. He is a much sought-after speaker who has delivered 87 named lectures and keynote addresses and over 1,200 scientific presentations in 49 countries. In recognition of his outstanding contributions and world leadership in Head and Neck surgery, Memorial Sloan Kettering Cancer Center has established an endowed Chair in his name, the American Head and Neck Society has named an annual symposium in his honor, and the IFHNOS has established an eponymous lecture in his name at its World Congresses.

Ashok R. SHAHA

MD, FACS

Professor Ashok Shaha is an Attending Surgeon on the Head and Neck Service at Memorial Sloan Kettering Cancer Center, Professor of Surgery at Cornell University Medical College, and holds the Jatin Shah Chair in Head and Neck Surgery at MSKCC. Dr. Shaha completed his surgical training at M.S. University of Baroda and at The Tata Memorial Hospital in India. He completed his surgical training at Downstate Medical Center in Brooklyn, New York and a fellowship in Head and Neck surgery at Memorial Hospital. He joined the Department of Surgery at Downstate Medical Center in 1982 as a Head and Neck Surgeon, rising to the rank of Professor of Surgery in 1992. During this period, he was also Chief of Head and Neck Surgery at King’s County, Brooklyn VA Hospital and University Hospital. He joined the full time faculty of MSKCC in 1993. Dr. Shaha has been awarded many honors throughout his career. He has served as President of the New York Head and Neck Society, the American Society for Surgeons of Indian Origin, the Brooklyn Surgical Society, the New York Cancer Society, the New York Surgical Society, the American Head and Neck Society, and the American Association of Endocrine Surgeons. His CV includes more than 500 publications. Dr. Shaha has dedicated his professional career to the training of medical students, residents and fellows. He was Chairman of the Advanced Training Council for Head and Neck Surgery and Oncology Fellowships in the USA.

Joseph CALIFANO

MD

Joseph Califano, MD, is an internationally recognized physician scientist who has translated multiple discoveries from his own laboratory into the clinic, including detection of HPV-related and other head and neck cancers. Dr. Califano is Professor of Surgery and Vice Chief of the Division of Otolaryngology-Head and Neck Surgery, Department of Surgery as well as Director, Head and Neck Cancer Center, Moores Cancer Center at UC San Diego Health. His major focus is the clinical practice of head and neck surgical oncology and the integration of basic, molecular biologic research in that practice. A graduate of Harvard Medical School, Dr. Califano performed his Otolaryngology-Head and Neck Surgery residency at Johns Hopkins Hospital, and completed a fellowship in head and neck surgical oncology at Memorial Sloan-Kettering Cancer Center. He then joined the faculty of Johns Hopkins and ultimately became Professor in the Head and Neck Division and the Division of Head and Neck Cancer Research at John Hopkins Department of Otolaryngology-Head and Neck Surgery before moving to UCSD. His surgical practice focuses on minimally invasive treatment of tumors of the larynx, pharynx, and neck, as well as treatment of premalignant conditions of the upper aerodigestive tract. Dr. Califano also currently directs an NIH funded laboratory investigating the molecular biologic basis of head and neck cancer. He has published over 280 peer reviewed articles related to both the clinical and basic scientific aspects of cancer, and currently serves as a member of the NCI Head and Neck Steering Committee and Council Member of the American Head and Neck Society as well as other professional organizations and editorial boards

Alan HO

.

Dr. Ho, a medical oncologist specializing in the management of malignancies of the head and neck. His academic interests focus on rare cancers, specifically molecular subsets of head and neck squamous cell carcinomas, RAI-refractory thyroid cancers, and salivary cancers. He currently serves in several national and international positions of leadership to promote the development and conduct of translational trial concepts in rare diseases, including as a Board Member for the International Thyroid Oncology Group, Chair of the head and neck subsection of the International Clinical Trials in Rare Cancers Initiative, and Member of the Experimental Therapeutics Committee of the Alliance Cooperative Group, National Comprehensive Cancer Network Investigator Steering Committee, NCI Head and Neck Steering Committee, and NCI Head and Neck Rare Tumors Task Force.

June CORRY

.

Professor June Corry is an internationally recognised Head and Neck Radiation Oncologist. She has dual medical oncology and radiation oncology qualifications. She was the Head of the Peter MacCallum Cancer Center H&N Service for 15 years and is now working with Genesis Care St Vincents Hospital Melbourne. She has served as the President of the ANZHNCS, TROG Executive / Publications / ANROTAT Committees, and the Chair of WCMICS and VCOG. She was a Founding Member of IAOO. She is on the Editorial board of JCO, IJROBP, OO and H&N journals. She has published over 120 manuscripts in peer review journals and multiple book chapters. She has a strong belief in collaborative clinical research and patient advocacy

Barbara WOLLENBERG

.

Dr. Barbara Wollenberg is Professor and Chair of the Department of Otolaryngology-Head & Neck in Lübeck at the University Hospital of Schleswig Holstein (UK-SH). She absolved her surgical education at the Department for Otolaryngology and Head and Neck Surgery at Großhadern Medical Centre, Ludwig-Maximilians-University Munich (LMU) gaining a broad surgical spectrum throughout otorhinolaryngology, frontal and lateral skull base surgery and reconstructive head and neck surgery. Simultaneously, she achieved a PhD in immunology. In 2001, she became a Heisenberg Scholar - a highly competitive research scholarship funded by the DFG (German Research Foundation). In the past, Dr. Wollenberg has held various other highly-respected positions, including the Subdean at the University of Lübeck (2004-2012), and Board Member of the Working Committee Otorhinolaryngology, Cranio-Maxillo-Facial Surgical Oncology of the German Cancer Society (AHMO, President: 2015-2017) President of the German Society for Otorhinolaryngology and Head and Neck Surgery (2017/2018). Currently, she is one of the senators of the German Research Foundation DFG and the German National Academy of Science Leopoldina. She is member of various scientific societies, member of several editorial boards of International journals and reviewer of multiple cancer journals. From the beginning of the residency, Dr. Wollenberg is fascinated by oncologic research. She built up a large team from biologists and physicians predominantly focused on immunologic research at the border between the tumor and the immune system and the development of 'Immunological Therapies of HNSCC'. In this setting, she was very successful in winning research awards, raising grant funding and publishing in peer reviewed journals and books. Dr. Wollenberg is a passionate teacher in the laboratory as well as in clinic.

© 2019 by Eurasian Federation of Oncology | Terms of Use | Privacy Policy